IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 223 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $747,000 | +522.5% | 124,691 | +256.3% | 0.04% | +218.2% |
| Q4 2020 | $120,000 | +287.1% | 35,000 | -13.2% | 0.01% | +120.0% |
| Q3 2020 | $31,000 | +158.3% | 40,300 | -11.4% | 0.01% | +150.0% |
| Q2 2020 | $12,000 | -99.6% | 45,500 | -81.4% | 0.00% | -99.7% |
| Q1 2020 | $3,393,000 | +5120.0% | 244,106 | +1219.5% | 0.78% | +12883.3% |
| Q4 2019 | $65,000 | +30.0% | 18,500 | -73.9% | 0.01% | -53.8% |
| Q3 2019 | $50,000 | – | 70,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |